Canadian listed Chorus Aviation (CHR) reported earnings results for the quarter ended June 2011. Earnings came in at $0.13 per share compared to analyst estimates of $0.11 per share. Actual earnings beat estimated earnings by $0.02 per share. Investors could expect the stock price to increase as results were better than expected. Further analysis may need to be done to determine whether the upswing will come to effect. Guidance and revenue estimates must be taken into consideration.
Ballantyne Strong, Inc (BTN) reported earnings results for the quarter ended June 2011. Analysts were expecting $0.15 per share, and the company reported $0.17 per share. Actual earnings beat estimated earnings by $0.02 per share. Investors could expect the stock price to rise on better than expected results. Further analysis on other trends may need to be completed to determine whether the upswing will be confirmed. Guidance, stock price, and revenue estimates must be considered as well. Shares of BTN remained unchanged at $3.60. In the past year, the shares have traded as low as $3.18 and as high as $9.74. On average, 204383 shares of BTN exchange hands on a given day and today's volume is recorded at 3416.
Adventrx Pharmaceuticals, Inc (ANX) announced their most recent earnings results for the quarter ended in June 2011. The company reported $-0.12 per share when analysts were expecting earnings of $-0.13. Earnings beat analyst estimates by 7.69%. Investors could expect the stock price to rise on better than expected results. Further analysis on other trends may need to be completed to determine whether the upswing will be confirmed. Guidance, stock price, and revenue estimates must be considered as well. Shares of ANX traded higher by 10.05% or $0.21/share to $2.30. In the past year, the shares have traded as low as $1.73 and as high as $4.21. On average, 1016990 shares of ANX exchange hands on a given day and today's volume is recorded at 55875.
Cellcom Israel Ltd (CEL) reported earnings results for the quarter ended June 2011. Analysts were expecting $0.78 per share, and the company reported $0.72 per share. Earnings were unexpectedly -7.69% lower than estimated. Investors could expect the stock price to decrease as earnings were worse than expected. Further analysis may need to be conducted to determine whether the downswing will occur. A total of 4 analysts are currently covering this company. Shares of CEL fell by 3.7% or $-0.97/share to $25.22. In the past year, the shares have traded as low as $25.75 and as high as $35.35. On average, 337852 shares of CEL exchange hands on a given day and today's volume is recorded at 508870.
Albany Molecular Research Inc (AMRI) announced their most recent earnings results for the quarter ended in June 2011. Analysts were expecting $-0.03 per share, and the company reported $-0.02 per share. Actual earnings beat estimated earnings by $0.01 per share. Investors could expect the stock price to rise on better than expected results. Further analysis on other trends may need to be completed to determine whether the upswing will be confirmed. Guidance, stock price, and revenue estimates must be considered as well. There is currently 1 analyst covering this firm. Investors can look to their reports for more information. Shares of AMRI fell by 1.56% or $-0.06/share to $3.79. In the past year, the shares have traded as low as $3.85 and as high as $6.97. On average, 95414 shares of AMRI exchange hands on a given day and today's volume is recorded at 2700.
